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We summarize here our new discovery that the endogenous opioid peptide b-endorphin (BEP), by virtue of reducing
body stress and maintaining active immune system, as well as, balancing the levels of pro-inflammatory and anti-
inflammatory cytokines, destroys tumor cells and stops them from being transformed into metastatic cancer cells.
Body and mind interact extensively with
each other in control of a person’s health.
Social and psychological stress can trigger
or aggravate a wide variety of diseases and
disorders. Accumulating data on animals
and humans have shown the connection
between the body’s psychophysiologic
reaction during stress and an increased
incidence or relapse of cancer.
1 Activation
of sympathetic nervous system, such as
what happens in the “fight or flight” res-
ponse, downregulates tumor-suppressive
genes, inhibits immune function and pro-
motes tumor growth. On the other hand,
an optimistic attitude or psychological
intervention helps cancer patients to
survive longer. How this works is currently
not clear. According to the research of
our lab, this effect may be related to the
β-endorphin (BEP), an endogenous pep-
tide molecule, which has morphine-like
activities.
BEP was first isolated by neurochemist
Choh Hao Li at the University of
California in San Francisco from dried
camel pituitary. It was first found to have
a strong effect in pain perception, 48
times more powerful than morphine when
administered into the brain.
2 Now it is
known that BEP has a profound effect
in the inhibition of stress behavior and
stress hormone production, production of
analgesia and a feeling of well-being. In
the brain, BEP producing perikarya are
primarily found in the arcuate nucleus,
3
where they send projections to many
brain areas, particularly within the hypo-
thalamus.
4 It has been shown that BEP
not only inhibits the stress response
of hypothalamic-pituitary-adrenal axis
through interaction with corticotrophin-
releasing hormone neurons in the para-
ventricular nucleus (PVN), but also
inhibits the sympathetic nervous system
(SNS) through innervations of the PVN
where these BEP molecules bind to d-
and m-opioid receptors to modulate the
neurotransmission in neurons of the auto-
nomic nervous system. Abnormalities in
BEP neuronal function are correlated with
a higher incidence of cancers and infec-
tions in patients with schizophrenia,
depression, fetal alcohol syndrome, and
obesity.
5
All these observations brought us the
thought: whether an increase of BEP level
will suppress the stress response, improve
health, and most importantly, inhibit
cancer? The answer was yes. Previous
work from our lab showed that intracranial
administration of BEP enhanced immune
activity. BEP could enhance the produc-
tion of interferon-gamma and granzyme B,
promote splenic lymphocyte proliferation
during an immune challenge, and increase
cytotoxicity of natural killer cells through
action on d- and m-opioid receptors.
6,7
The effect of intracranial infusion of BEP
is transient. Therefore, we looked into
further measures to establish a permanent
source of BEP in the brain.
In light of this thinking, we have
recently developed a method to differenti-
ate β-endorphin neurons in vitro from
hypothalamic neuronal stem cell using a
cAMP analog. Previous study of alcohol-
caused BEP neuronal death revealed that
cAMP is critical for the survival and
differentiation of hypothalamic BEP
cells.
8 When a stable analog of cAMP is
added to in vitro cultured hypothalamic
neuronal stem cells, these cells could
differentiate to a group of highly pure
BEP neurons.
9 By transplanting these
neurons into the PVN of the hypothal-
amus, we could increase both POMC
gene expression and BEP production in
the PVN. These transplanted neurons
were shown to integrate well in the
PVN, and could survive for at least
8 mo. During this period of time, these
animals were shown to have decreased
stress response to both immune challenge
and behavior stressors, and increased peri-
pheral innate immune cell function, such
as higher natural killer cell cytotoxicity
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and macrophage migration activity. The
anti-inflammatory cytokine levels were
increased in their plasma, at the same
time, inflammatory cytokine levels were
found to be decreased.
5 As expected, BEP
transplantation had an extensive effect in
inhibition of tumor progression in several
cancer models, including prostate cancer,
10
breast cancer and lung metastasis of
mammary adenocarcinoma cells.
5
This effect is possibly regulated through
the action of BEP on the sympathetic
and parasympathetic nervous system.
Primary and secondary lymphoid organs,
which include the thymus, spleen and
lymph nodes, receive extensive autonomic
input.
10 Administration of an opiate
receptor blocker naloxone, a β-receptor
agonist metaproterenol, or an acetylcho-
line receptor blocker methyllycaconitine
all could inhibit the immune-enhancing
and tumor-preventing effects by trans-
plantation of BEP cells. These data
indicate that BEP peptides in transplanted
animals bind to opioid receptors, suppress
the SNS and activate the parasympathetic
nervous system, and finally, regulate
immune function and tumor growth.
Current treatments of cancer focus on
the physical removal of tumors and the
destruction of dividing cells, such as
chemotherapy and radiation therapy.
These treatments are not specific, in that
they also destroy normal cells that are
programmed to be proliferating. This
causes many side effects such as hair loss
and nausea, and at the same time, weakens
the body’s defense against pathogens as
well as tumors. These methods may also
fail to kill cancer stem cells, which are in
hibernation. Indeed, the body could
recognize and kill cancerous cells by itself
through immune surveillance. The trans-
formed tumor cells express antigens that
are not present in normal cells. Immune
cells can recognize these foreign antigens
and therefore attack and eliminate the
tumor cells. The BEP cell transplantation
procedure to treat cancer could potentially
be valuable, because it utilizes and opti-
mizes the body’s own defense system to
control abnormal cell proliferation, which
is more specific, and bypasses the problem
of current treatments.
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Figure1. b-endorphin (BEP) neuron in the hypothalamus controls the growth and progression of
tumor cells by modulating the neurotransmission in the autonomic nervous system and activating
immune cell functions. Effects include the stimulation of parasympathetic nervous system and
release of acetyl choline (Ach) and suppression of the sympathetic nervous system and release
of norepinephrine (NE) leading to activation of innate immune cells (including macrophages
and natural killer cells) of the lymphoid organ and an increase in cytotoxic immune cells and
anti-inflammatory cytokines levels in the circulation. In a tumor microenvironment these
immune cell and cytokine changes increase apoptotic death of tumor cells and reduce
inflammation-mediated epithelial-mesenchymal transition (EMT), and thereby suppress cancer
growth and progression. Collectively, these effects create an unfavorable environment for tumor
initiation, growth and progression.
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